Department of Surgery, Division of Surgical Oncology, Eppley Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
HPB (Oxford). 2012 Sep;14(9):635-45. doi: 10.1111/j.1477-2574.2012.00500.x. Epub 2012 Jun 19.
Surgical decision making for patients with early hepatocellular carcinoma (HCC) and well-compensated cirrhosis remains controversial. The aim of the current study was to conduct a meta-analysis of published reports to compare survival outcomes after transplantation and resection, respectively, in patients with early HCC [i.e. HCC falling within the Milan Criteria (a solitary lesion measuring ≤5 cm or fewer than three lesions with a largest diameter of ≤3 cm, and absence of macroscopic vascular invasion or extrahepatic disease)] and well-compensated cirrhosis.
A total of 990 abstracts were identified through a PubMed-based search. Ten articles comparing transplantation and resection in patients with early HCC were included in the meta-analysis. Meta-analysis was performed using stata 9.2 statistical software.
Outcomes were analysed for a total of 1763 patients with early HCC. The 5-year overall survival (OS) for all patients was 58% (transplantation: 63%; resection: 53%). Meta-analysis of all 10 studies revealed a survival advantage for transplantation [odds ratio (OR) 0.581, 95% confidence interval (CI) 0.359-0.939; P = 0.027]. Analysis of only those reports that utilized an 'intention-to-treat' strategy failed to demonstrate a survival advantage for either treatment approach (OR 0.600, 95% CI 0.291-1.237; P = 0.166).
The current study demonstrates a favourable outcome in patients with early HCC treated by either transplantation or resection. Although transplantation was noted to have a survival advantage in some settings, resection continues to be a viable treatment approach.
对于早期肝细胞癌(HCC)和代偿良好的肝硬化患者的手术决策仍存在争议。本研究的目的是对已发表的报告进行荟萃分析,以比较分别接受移植和切除术治疗的早期 HCC [即符合米兰标准(单个病变最大直径≤5cm 或不超过 3 个病变且最大直径均≤3cm,无肉眼血管侵犯或肝外疾病)]和代偿良好的肝硬化患者的生存结果。
通过基于 PubMed 的搜索共确定了 990 个摘要。共有 10 篇比较早期 HCC 患者移植和切除术的文章纳入荟萃分析。使用 stata 9.2 统计软件进行荟萃分析。
对总共 1763 例早期 HCC 患者进行了结果分析。所有患者的 5 年总生存率(OS)为 58%(移植:63%;切除:53%)。对所有 10 项研究的荟萃分析显示,移植具有生存优势[比值比(OR)0.581,95%置信区间(CI)0.359-0.939;P=0.027]。仅分析那些采用“意向治疗”策略的报告未能表明两种治疗方法都具有生存优势(OR 0.600,95%CI 0.291-1.237;P=0.166)。
本研究表明,早期 HCC 患者接受移植或切除术治疗都有较好的结果。虽然在某些情况下移植具有生存优势,但切除术仍然是一种可行的治疗方法。